Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell -Q1 group results

Aug 10 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            556 mln             666 mln           3.05     
                 (-16.6 pct)         (+74.2 pct)      (+3.2 pct)  
  Operating     loss 124 mln         loss 86 mln     loss 110 mln 
  Recurring        82 mln              42 mln           148 mln   
                 (+91.4 pct)                                      
  Net              72 mln              42 mln           148 mln   
                 (+70.1 pct)                                      
  EPS             0.85 yen            0.51 yen         1.74 yen   
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news